Blog Unherd: Will a vaccine stop Covid? October 21, 2020 GreenLight CEO, Andrey Zarur, speaks to Unherd about vaccine production for Covid-19. Credit: Juan Carlos Lucas/NurPhoto/Getty Images GreenLight CEO, Andrey Zarur, speaks to Unherd about the supply chain issues related to vaccine production and manufacturing for Covid-19. He said: “Making an adenovirus particle has never been scaled…there just aren’t enough reactors in the world [to create two billion doses by the end of the year]”.“When Moderna says they’re going to make a billion doses by the end of 2021…it’s about calling on suppliers and saying how much nucleotide can you make…But those are the same suppliers that Pfizer is calling! Those materials, the nucleotides and the enzymes, are in very short supply.”“[It is] a twist of fate [that] the vaccines that are in the lead are also the ones with the least developed supply chain” Read the full article here and a further mention in another article here.Find out more about how GreenLight manufactures RNA. More of GreenLight Biosciences in the news: STAT: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines Financial Times: Get vaccine new variant ready Mail Online: Vaccine roll out issues Financial Times: Vaccine makers race to fix vaccine supply issues Technology Review: What are the Pfizer covid-19 vaccine ingredients? Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped